# Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin

> **NCT01464944** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 392 (actual)

## Conditions studied

- Respiratory Tract Infections
- Fever

## Interventions

- **DRUG:** Acetylsalicylic acid (Aspirin, BAYE4465)
- **DRUG:** Acetylsalicylic acid (Aspirin, BAYE4465)
- **DRUG:** Paracetamol
- **DRUG:** Paracetamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01464944
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464944, "Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01464944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*